Cargando…
Genomic alterations of Tenascin C in highly aggressive prostate cancer: a meta-analysis
Tenascin C (TNC), an extra-cellular matrix (ECM) family gene, is expressed in several cancer tissues of breast, lung, colon, and gastrointestinal tract leading to proliferation, migration, invasion, angiogenesis and metastasis, but its role in tumorigenesis of prostate cancer is poorly understood. W...
Autores principales: | Mishra, Prachi, Kiebish, Michael A., Cullen, Jennifer, Srinivasan, Alagarsamy, Patterson, Aliyah, Sarangarajan, Rangaprasad, Narain, Niven R., Dobi, Albert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872669/ https://www.ncbi.nlm.nih.gov/pubmed/31798767 http://dx.doi.org/10.18632/genesandcancer.196 |
Ejemplares similares
-
Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer
por: Kiebish, Michael A., et al.
Publicado: (2020) -
Current Status of Metabolomic Biomarker Discovery: Impact of Study Design and Demographic Characteristics
por: Tolstikov, Vladimir, et al.
Publicado: (2020) -
Ethnic Prevalence of Angiotensin-Converting Enzyme Deletion (D) Polymorphism and COVID-19 Risk: Rationale for Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers
por: Sarangarajan, Rangaprasad, et al.
Publicado: (2020) -
Clinical utility of a serum biomarker panel in distinguishing prostate cancer from benign prostate hyperplasia
por: Kiebish, Michael A., et al.
Publicado: (2021) -
Metabolomic effects of androgen deprivation therapy treatment for prostate cancer
por: Chi, Jen‐Tsan, et al.
Publicado: (2020)